The chief scientist to the World Health Organization said on Tuesday she looked forward to the “second generation” of COVID-19 vaccines.
The vaccines included newer versions as opposed to the jabs the world has grown acquainted with. Instead, vaccines in forms of intra-nasal (nasal sprays) and oral versions are in the midst of production.
Dr. Soumya Swaminathan explained these vaccines may have advantages over the current version of vaccines requiring medical professionals to perform the jabs.
For one thing, people can perform self-administration with the new versions of vaccine.
According to Swaminathan, at present, 129 different candidate vaccine have gone as far as clinical trials (tested on humans). On the other hand, there are 194 others still in early development and require further advanced studies in laboratories.
On WHO’s live social media channels, she said the studies in progress encompasses an entire range of technologies. She shared high hopes for their development to eventually be proven safe and efficacious.
The ultimate goal is for the global population to be given a range of choices to choose from. Soon, we may choose vaccines that best fits our preferences.
Needless to say, this is great news for those afraid of needles, particularly towards children.